This review summarizes the role of c-MYC in B-cell lymphomas and leukemias, particularly in relation to the specific subtypes classified under the 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms [26]. This evidence concerns the gene MYC and B-cell non-Hodgkin lymphoma.